Evaluating Genpact (G) After Recent Share Price Weakness And A Claimed 25% Valuation Discount

Genpact stock moves: recent performance snapshot

Genpact (G) has drawn investor attention after a period of weaker share performance, with the stock showing a 2.2% decline over the past day and deeper losses over the past month and past 3 months.

See our latest analysis for Genpact.

At a share price of US$36.58, Genpact’s recent 7 day and 30 day share price returns of 5.48% and 7.91% declines, alongside a 1 year total shareholder return of 25.62% decline, suggest momentum has been fading as investors reassess growth prospects and risk.

If you are comparing Genpact with other business services and tech enabled names, it can help to widen the lens into related themes and opportunities via 20 top founder-led companies

With a recent share price of US$36.58, a value score of 6, an indicated intrinsic discount of 67% and annual revenue and net income growth in the single digits, are you seeing a mispriced opportunity or a market that is already baking in future growth?

Most Popular Narrative: 25% Undervalued

At a last close of $36.58 against a narrative fair value of $48.64, the most followed view frames Genpact as materially undervalued, with that gap anchored to detailed long term earnings and cash flow assumptions.

Genpact's strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, is presented as a basis for above-sector-average revenue and EPS growth, supported by operating margin expansion and continued return of capital to shareholders.

Read the complete narrative.

Want to see what is behind that valuation gap? The narrative focuses on compounding revenue, firmer margins, and a different earnings multiple than the market is applying today.

Result: Fair Value of $48.64 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on Advanced Technology Solutions offsetting slower legacy BPO growth and on large, multi year contracts converting as planned rather than slipping or shrinking.

Find out about the key risks to this Genpact narrative.

Next Steps

After considering the recent share price pressure and the undervaluation narrative, now is an appropriate moment to review the data yourself and determine how compelling the potential upside appears, starting with 5 key rewards

Looking for more investment ideas?

If Genpact has you thinking about risk, reward, and timing, do not stop here. Broaden your watchlist with focused stock ideas built from consistent, transparent data.

• Target higher potential by reviewing 62 high quality undervalued stocks that combine compressed valuations with stronger fundamentals than the market seems to be pricing in.
• Strengthen your income stream by scanning 12 dividend fortresses that pair 5%+ yields with an emphasis on durability.
• Sleep easier at night by assessing 64 resilient stocks with low risk scores that screen for resilient balance sheets and fewer red flags.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com